Replies to post #129711 on Biotech Values

[DewDiligence]

What about my second question?

Oops—I didn’t scan far enough down in your message to see it.

I presume that quantification of the reimbursement to MNTA of Lovenox development expenses will be furnished at MNTA’s 3Q11 CC on Nov 7.